Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis

• Published in: BMC nephrology Vol. 20; no. 1; pp. 398 - 12
• Main Authors: Zhang, Lijun, Wang, Yangyang, Xiong, Lianlian, Luo, Yanfang, Huang, Zhijun, Yi, Bin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 29.10.2019; BioMed Central; BMC
• Subjects: Analysis; Blood Pressure; Blood pressure measurement; Body Mass Index; Cardiovascular diseases; Care and treatment; Cholesterol - blood; Chronic kidney disease; Chronic kidney failure; Creatinine - blood; Exercise; Exercise Therapy; Glomerular filtration rate; Glomerular Filtration Rate - physiology; Humans; Kidney - physiology; Kidney diseases; Lipoproteins, HDL - blood; Lipoproteins, LDL - blood; Low density lipoproteins; Meta-analysis; Patient outcomes; Physical therapy; Randomized controlled trial; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - therapy; Retirement benefits; Triglycerides; Triglycerides - blood; Uncertainty; China; Chronic kidney disease; Randomized controlled trial; Exercise therapy; Meta-analysis
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-019-1586-5

Patients with chronic kidney disease (CKD) have a high prevalence of cardiovascular diseases, which often lead to physical inactivity that correlates with CKD exacerbation. The benefits of regular exercise to cardiovascular health have been well established in healthy population and highly suggestive in patients with CKD. To further strengthen the evidence base for the management of CKD, this meta-analysis was performed to systematically evaluate the effects of exercise therapy on renal function, blood pressure, blood lipid and body mass index (BMI) in non-dialysis CKD patients. This meta-analysis was conducted following a previous protocol. Randomized controlled trials (RCTs) examining the effects of exercise therapy in non-dialysis CKD patients were searched in Pubmed, Embase, Cochrane Library, and three major Chinese biomedical databases (CNKI, WANGFANG and VIP) from their start date to October 30th, 2018. The Cochrane systematic review methods were applied for quality assessment and data extraction, and Revman version 5.3 was used for systematic review and meta-analysis. 13 RCTs, representing 421 patients with non-dialysis CKD, were included in this meta-analysis. Compared to the controls, exercise therapy brought an increase in eGFR (MD = 2.62, 95% CI:0.42 to 4.82, P = 0.02, I  = 22%), and decreases in systolic blood pressure (SBP) (MD = -5.61, 95% CI:-8.99 to - 2.23, P = 0.001, I  = 44%), diastolic blood pressure (DBP) (MD = -2.87, 95% CI:-3.65 to - 2.08, P < 0.00001, I  = 16%) and BMI (MD = -1.32, 95% CI:-2.39 to - 0.25, P = 0.02, I  = 0%) in non-dialysis CKD patients. Exercise therapy of short-term (< 3 months) decreased triglyceride (TG) level (P = 0.0006). However, exercise therapy did not significantly affect serum creatinine (SCr), total cholesterol (TC), high density lipoprotein (HDL) or low density lipoprotein (LDL) in non-dialysis CKD patients. Exercise therapy could benefit non-dialysis CKD patients by increasing eGFR while reducing SBP, DBP and BMI. Additionally, short-term intervention of exercise could decrease TG.